Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 7

Results For "EIR"

3316 News Found

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’
Biotech | May 06, 2022

ACI Hospitals celebrates the spirit of women with their new campaign ‘WOWMOM’

The campaign aims to promote women’s health and wellness and urge them to visit the hospital for key medical check-ups


BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa
Sustainability | March 17, 2022

BASF and Beyond Suncare renew their cooperation to protect people with albinism in Africa

Over the next three years, BASF will continue to support Beyond Suncare by supplying the required raw materials free of charge and by providing technical expertise to further improve the formulation


AstraZeneca India appoints Ram Mudaliar as India lead of their CDI division
People | January 20, 2022

AstraZeneca India appoints Ram Mudaliar as India lead of their CDI division

Ram’s appointment follows the launch of the CDI India division in October 2021.


Lupin’s Goa plant receives EIR from US FDA
News | December 14, 2021

Lupin’s Goa plant receives EIR from US FDA

FDA changes inspection classification of the facility to Voluntary Action Indicated


Premas Biotech and Oravax to test their vaccine candidate against Omicron
News | December 02, 2021

Premas Biotech and Oravax to test their vaccine candidate against Omicron

Oravax's vaccine technology is highly scalable for manufacturing and is easily transferable for wide scale logistical distribution, as there is no need for freezer storage


Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.
Biotech | September 09, 2021

Eirion Therapeutics mandates HTL Biotechnology to be its exclusive Botulinum API manufacturer.

HTL will build, validate and operate a botulinum manufacturing facility in the US


Zydus and Bayer announce extension of their JV
News | June 21, 2021

Zydus and Bayer announce extension of their JV

Bayer Zydus Pharma will continue to operate in core therapies with new products in the pipeline


We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET
interviews | April 22, 2026

We believe in trust-driven clinical conversations to cut through medical misinformation: Saurav Kasera, Founder, CLIRNET

CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice


Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%
Clinical Trials | April 22, 2026

Roche’s MS drug fenebrutinib delivers striking Phase III results by cutting relapse rates by 58%

The company announced that its Phase III FENhance 1 and 2 studies both met their primary endpoints


HCL Healthcare opens Bengaluru office to deepen enterprise client engagement
Healthcare | April 22, 2026

HCL Healthcare opens Bengaluru office to deepen enterprise client engagement

New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients